Health care industry

FILE - This April 26, 2017, file photo shows the Eli Lilly & Co. corporate headquarters in Indianapolis. Eli Lilly is buying Loxo Oncology for about $8 billion as it continues to broaden its cancer treatment efforts. Loxo Oncology Inc. is a biopharmaceutical company focused on the development and commercialization of highly selective medicines for patients with genomically defined cancers. (AP Photo/Darron Cummings, File)
January 07, 2019 - 4:49 am
Eli Lilly is spending about $8 billion in cash to buy Loxo Oncology, as the drugmaker bulks up on cancer treatments that target certain gene abnormalities. Loxo Oncology could launch a drug next year and targets an abnormality that occurs in several tumor types, including some lung and thyroid...
Read More
CAPTION CORRECTS DATE TO FEB. 4, 2009 In this Feb. 4, 2009 photo, a view of the exterior of the University Hospital in Enkoping, Sweden, Friday, Jan. 4, 2019. Officials say a Swedish hospital has reported a suspected case of the deadly Ebola virus, adding the patient has been isolated. Region Uppsala, which oversees several hospitals and medical clinics north of Stockholm, says a test had been carried out on the patient who was not identified, adding a result would be available late Friday, Jan. 4, 2019. (Henrik Montgomery/TT News Agency via AP)
January 05, 2019 - 2:21 am
HELSINKI (AP) — Swedish health officials say a suspected Ebola case reported by a hospital has turned out to be a false alarm with tests carried out on the unidentified patient showing no signs of the deadly virus. Medical authorities said late Friday that the young male patient was admitted to an...
Read More
FILE - In this June 15, 2005, file photo, a sign stands in front of a Bristol-Myers Squibb building in a Lawrence Township, N.J. Bristol-Myers Squibb is buying Celgene in a cash-and-stock deal valued at about $74 billion. (AP Photo/Mel Evans, File)
January 03, 2019 - 3:00 pm
SUMMIT, N.J. (AP) — Bristol-Myers Squibb is spending $74 billion on fellow drugmaker Celgene in a deal aimed at stocking the combined company's development pipeline with cancer, immunology and cardiovascular treatments. Bristol would gain the cancer treatment Revlimid in the cash-and-stock deal...
Read More
An injured man is assisted after being wounded in a bomb blast near the presidential palace in the capital Mogadishu, Somalia. Saturday, Dec. 22, 2018. Police say a suicide car bomb detonated near the presidential palace killing and wounding a number of people. (AP Photo/Farah Abdi Warsameh)
December 24, 2018 - 5:06 am
MOGADISHU, Somalia (AP) — The death toll rose to 26 from Saturday's twin bombings in Somalia's capital, police and hospital sources said Monday. The number rose because several victims of the suicide car blast near the rear entrance of the presidential palace died in hospitals in Mogadishu, said...
Read More
Stock trader Michael Milano works at the New York Stock Exchange, Wednesday, Dec. 19, 2018. (AP Photo/Mark Lennihan)
December 19, 2018 - 12:42 pm
NEW YORK (AP) — Stocks gave up an early rally and took a dive in afternoon trading after the Federal Reserve's raised interest rates again and said it plans to keep raising them next year. The U.S. central bank also said it wouldn't make any changes in allowing its large bond portfolio to shrink...
Read More
FILE - This April 20, 2009 file photo, shows the British pharmaceuticals firm GlaxoSmithKline in London. Drugmakers GlaxoSmithKline and Pfizer are merging their healthcare divisions, creating a business with combined sales of 9.8 billion pounds ($12.7 billion). British-based Glaxo will own 68 percent of the joint venture, while U.S.-based Pfizer will own the remaining 32 percent stake. (AP Photo/Sang Tan, File)
December 19, 2018 - 10:18 am
Drugmakers GlaxoSmithKline and Pfizer plan to merge their consumer health businesses into what will be the world leader in sales of nonprescription medicines such as pain relievers, vitamins and cold remedies. The new joint venture would have with combined annual sales of $12.7 billion (9.8 billion...
Read More
FILE- In this Dec. 12, 2018, file photo trader Gregory Rowe works at the New York Stock Exchange in New York. The U.S. stock market opens at 9:30 a.m. EST on Monday, Dec. 17. (AP Photo/Mark Lennihan, File)
December 17, 2018 - 1:13 pm
NEW YORK (AP) — The latest on developments in financial markets (all times local): 4 p.m. The Dow Jones Industrial Average plunged 500 points, its second straight drop of that size and its fourth big decline this month. Longtime market favorites like Microsoft and Amazon took heavy losses Monday...
Read More
December 12, 2018 - 9:22 am
ST. PAUL, Minn. (AP) — Minnesota lawmakers are considering steps they could take to rein in the soaring cost of insulin, which one couple says has become so expensive that their diabetic son could no longer afford it and died. State Sen. Matt Little convened an informal discussion at the state...
Read More
In this Aug. 16, 2010 file photo a nurse looks on from a window of the Giulesti hospital following a fire that left 5 newborn babies dead. Romanian health authorities on Friday, Nov. 30, 2018, temporarily closed the maternity hospital in the capital after over a dozen babies born there recently were diagnosed with a drug-resistant superbug. The Health Ministry said the hospital would stop admissions after the newborns were recently diagnosed with antibiotic-resistant Staphylococcus aureus. (AP Photo/Vadim Ghirda, File)
December 10, 2018 - 8:05 am
BUCHAREST, Romania (AP) — The number of babies diagnosed with a drug-resistant superbug at a maternity hospital in Romania's capital has risen to 39, authorities said Monday. Raluca Alexandru, spokeswoman for Giulesti Maternity hospital, closed Nov. 30 due to the outbreak, said tests have confirmed...
Read More
This image provided by Sandoz Inc. shows a new epinephrine injector by Sandoz, Inc. Amid persistent shortages of EpiPens and other emergency autoinjectors that treat life-threatening allergic reactions, generic drugmaker Sandoz says that early next year it will launch a slightly cheaper rival in the U.S. Sandoz said Thursday, Dec. 6, 2018, that it plans to sell a pair of its generic autoinjectors for $250 without insurance. (Sandoz Inc. via AP)
December 06, 2018 - 4:27 pm
TRENTON, N.J. (AP) — Generic drugmaker Sandoz announced plans Thursday to start selling an alternative to the EpiPen in the U.S. early next year. The EpiPen injector is used to halt life-threatening allergic reactions to insect bites, nuts and other foods. Brand-name EpiPen, which dominates the...
Read More

Pages